Table 4. Demographic data and virus detection frequencies in patients according to categories of adenotonsillar disease.
| Clinical feature/virus detection | RTN (%) | THN (%) | Non RT-THN (%) | RT/THN (%) |
| Patients (N) | 11 (9.09) | 49 (40.49) | 11 (9.09) | 50 (41.33) |
| Females | 7 (63.63) | 22 (44.89) | 2 (18.18%) | 27 (54%) |
| Age (mean in years) | 5.91 | 5.85 | 7.09 | 6.33 |
| All Viruses + | 11 (100) | 48 (97.96) | 10 (90.90) | 49 (98) |
| virus co-infections + | 8 (72.72) | 33 (67.34) | 7 (63.63) | 34 (68) |
| Virus + in palatine tonsils | 8 (72.72) | 34 (69.38) | 5 (45.45) | 36 (72) |
| Virus co-infections in palatine tonsils | 1 (9.09) | 8 (16.32) | 4 (36.36) | 12 (24) |
| HAdV + | 5 (45.45) | 20 (40.81) | 6 (54.54) | 26 (52) |
| HAdV + isolated | 1 (9.09) | 1 (2.04) | 1 (9.09) | 2 (4) |
| HAdV + in palatine tonsils | 3 (27.27) | 10 (20.41) | 3 (27.27) | 13 (26) |
| HAdV + isolated in palatine tonsils | 2 (18.18) | 2 (4.08) | 0 (0) | 7 (14) |
| HBoV + | 3 (27.27) | 16 (32.65) | 1 (9.09) | 16 (32) |
| HBoV + isolated | 0 (0) | 1 (2.05) | 0 (0) | 1 (2) |
| HBoV + in palatine tonsils | 1 (9.09) | 2 (4.08) | 0 (0) | 3 (6) |
| HBoV + isolated in palatine tonsils | 1 (9.09) | 0 (0) | 0 (0) | 1 (2) |
| HRV + | 3 (27.27) | 16 (32.65) | 4 (36.36) | 23 (46) |
| HRV + isolated | 2 (18.18) | 5 (10.20) | 0 (0) | 3 (6) |
| HRV + in palatine tonsils | 1 (9.09) | 4 (8.16) | 3 (27.27) | 7 (14) |
| HRV + isolated in palatine tonsils | 1 (9.09) | 3 (6.12) | 0 (0) | 1 (2) |
| HEV + | 5 (45.45) | 23 (46.94) | 2 (27.27) | 19 (38) |
| HEV + isolated | 0 (0) | 6 (12.24) | 0 (0) | 7 (14) |
| HEV + in palatine tonsils * | 4 (36.36) | 23 (46.94) | 1 (9.09) | 17 (34) |
| HEV + isolated in palatine tonsils * | 3 (27.27) | 18 (36.73) | 0 (0) | 12 (24) |
| HRSV + | 3 (27.27) | 8 (16.32) | 3 (27.27) | 5 (10) |
| HRSV + isolated | 0 (0) | 1 (2.04) | 0 (0) | 1 (2) |
| HRSV + in palatine tonsils | 0 (0) | 1 (2.04) | 1 (9.09) | 1 (2) |
| HRSV + isolated in palatine tonsils | 0 (0) | 1 (2.04) | 0 (0) | 1 (2) |
| HMPV + | 1 (9.09) | 3 (6.12) | 3 (27.27) | 14 (28) |
| HMPV + isolated | 0 (0) | 1 (2.04) | 1 (9.09) | 1 (2) |
| HMPV + in palatine tonsils | 0 (0) | 2 (4.08) | 2 (18.18) | 9 (18) |
| HMPV + isolated in palatine tonsils | 0 (0) | 1 (2.04) | 1 (9.09) | 2 (4) |
| FLU + | 1 (9.09) | 4 (8.16) | 1 (9.09) | 1 (2) |
| FLU + isolated | 0 (0) | 0 (0) | 1 (9.09) | 0(0) |
| FLU + in palatine tonsils | 0 (0) | 0 (0) | 0 (0) | 1(2) |
| FLU + isolated in palatine tonsils | 0 (0) | 0 (0) | 0 (0) | 0(0) |
| HPIV + | 0 (0) | 3 (6.12) | 0 (0) | 3 (6) |
| HPIV + isolated | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| HPIV + in palatine tonsils | 0 (0) | 1 (2.04) | 0 (0) | 2 (4) |
| HPIV + isolated in palatine tonsils | 0 (0) | 1 (2.04) | 0 (0) | 0 (0) |
| HCoV + | 0 (0) | 1 (2.04) | 0 (0) | 3 (6) |
| HCoV + isolated | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| HCoV + in palatine tonsils | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| HCoV + isolated in palatine tonsils | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
RT: Recurrent Tonsillitis; TH: Tonsilar Hypertrophy (Brodsky grade >3); non RT/TH: patients with smaller size tonsils (less than Brodsky 3) and without recurrent tonsillitis; RT/TH: Recurrent Tonsillitis and Tonsilar Hypertrophy.
*
p≤0.05.